All
Precise Radiation to the Tumor Is Safe and Effective in Treating Patients with Liver Cancer
December 17th 2019Patients with hepatocellular carcinoma whose tumors couldn’t be surgically removed lived longer and experienced few side effects after stereotactic body radiotherapy, according to phase 2 study findings.
CAR-T Cell Therapies Could Change the Mantle Cell Lymphoma Landscape
December 14th 2019However, the recent addition of new chemotherapy-free options such as chimeric antigen receptor (CAR)-T cell therapy could offer hope for patients with mantle cell lymphoma who develop resistance to chemotherapy-based treatment.
BTK Inhibitors Could Replace Chemotherapy in Mantle Cell Lymphoma Treatment
December 13th 2019While chemotherapy is widely used in the frontline treatment of mantle cell lymphoma (MCL), earlier use of BTK inhibitors such as Imbruvica (ibrutinib) may soon make chemotherapy obsolete for some patients, according to new data presented at the 2019 American Society of Hematology (ASH) Annual Meeting.
The Importance of Treatment-Free Survival in Cancer Care Planning
December 5th 2019In cancer clinical trials, the goal, or primary endpoint, is often focused on overall survival. However, one expert from the Dana Farber Cancer Institute thinks treatment-free survival should also be documented to provide patients with the data they need to make informed treatment choices.
FDA Approves Frontline Tecentriq/Chemotherapy for Metastatic Non-Squamous NSCLC
December 4th 2019The Food and Drug Administration approved Tecentriq in combination with chemotherapy for the first-line treatment of adults with metastatic non-squamous non-small cell lung cancer without EGFR or ALK mutations.